SEP 12, 2019 10:30 AM PDT

Analysis of human gut microbiomes and antibiotic resistomes of pediatric patients undergoing stem cell transplantation

SPONSORED BY: QIAGEN
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Director of Global Product Management, Genome Analysis, QIAGEN
    Biography
      Jonathan Jacobs Ph.D. has over 18 years of experience in bioinformatics, molecular genetics, and microbial genomics. In 1999, he received his BSc. in Plant Biology from the University of Arizona's College of Agriculture, and in 2006 he earned his PhD in Molecular Genetics from the University of Maryland, College Park. Dr. Jacobs was then awarded a Postdoctoral Research Fellowship at the National Cancer Institute, where his research focused on epigenetic control of gene expression. Following his postdoc, he obtained several patents in cell line engineering while a scientist in MedImmune's Antibody Discovery & Protein Engineering group. He later went on to join MRIGlobal to lead applied genomics programs. For eight years, Dr. Jacobs led MRIGlobal's pathogen genomics and bioinformatics team, developing systems for mobile pathogen diagnostics, microbial forensics, and point-of-need field testing. He was also the genomics team lead for U.S. Defense Threat Reduction Agency's S2S/PanGIA program: a deployable metagenomics system for use in clinical diagnostic and environmental surveillance laboratories. Dr. Jacobs joined QIAGEN in 2018 as Director of Global Product Management, Genome Analysis, where he is leading the development road-map for CLC bio, a portfolio of enterprise level bioinformatics software solutions.

    Abstract:

    The emergence and spread of antimicrobial-resistant (AMR) bacteria and resistance mechanisms pose a serious challenge to laboratories in both hospital clinical microbiology and public health settings. Accordingly, elevated vigilance by antibiotic stewardship programs at a local level is required to limit the spread and dissemination of drug-resistant pathogens among clinical patient populations. Whole genome sequencing, as opposed to traditional culturing and isolate typing, is proving to be an effective means to rapidly assess patient samples for the presence of potentially drug-resistant pathogens. The cost of whole genome sequencing continues to decline; however, there is an increasing need for effective bioinformatic analysis pipelines suitable for routine use by clinical microbiology laboratories.


    In this presentation, we use QIAGEN’s CLC Microbial Genomics Module, an extension to the CLC Genomics Workbench software platform, and the new QIAGEN Microbial Insights AR Database (QMI-AR), to analyze public gut microbiome data obtained from pediatric stem cell transplantation patients. We demonstrate how CLC Genomics Workbench platform, along with the QMI-AR database, can be used to profile microbiome samples for their constituent bacteria, and identify genomic markers for antimicrobial resistance. Furthermore, we demonstrate how the CLC platform can be used to build customized analysis workflows designed to automate the analysis and reporting of results, an essential component of any laboratory where standard operating procedures and rigorous results reporting are expected and required.


    Learning Objectives:

    1. Detect antimicrobial resistance genes using multiple methods and databases, including the new QIAGEN Microbial Insights AR database.
    2. Determine the taxonomic profile of shotgun metagenomic samples
    3. Build reproducible workflows for routine analysis
    4. Use tools from CLC Microbial Genomics Module to identify potential mobile AMR markers found in plasmids
    5. Visualize these markers in a reference genome using the new Genome Browser


    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    JUL 31, 2019 09:00 AM PDT
    C.E. CREDITS
    JUL 31, 2019 09:00 AM PDT
    DATE: July 31, 2019TIME: 9:00am PT, 12:00pm ET The choroid plexus, which makes up the blood-cerebrospinal fluid barrier in the central nervous system (CNS), lines the ventricle...
    AUG 15, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 15, 2019 09:00 AM PDT
    DATE: August 15, 2019TIME: 9:00am PDT, 12:00pm EDT Radiation therapy is a critical tool for the treatment of brain tumors, however, exposure to high doses of ionizing radiation...
    MAY 23, 2019 09:00 AM PDT
    C.E. CREDITS
    MAY 23, 2019 09:00 AM PDT
    DATE:  May 23, 2019TIME:   9:00am PDT, 12:00pm EDT Although mesenchymal stem/stromal cells (MSCs) chondrogenic differentiation has been thoroughly investigated...
    Loading Comments...
    Show Resources